Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.
复制标题
SARS-COV-2血清学测定法的评估显示了一系列测试性能。
DOI:
10.1038/s41587-020-0659-0
复制
发表时间:
2020-10
影响因子:
46.9
通讯作者:
Marson A
中科院分区:
文献类型:
--
作者:
Whitman JD;Hiatt J;Mowery CT;Shy BR;Yu R;Yamamoto TN;Rathore U;Goldgof GM;Whitty C;Woo JM;Gallman AE;Miller TE;Levine AG;Nguyen DN;Bapat SP;Balcerek J;Bylsma SA;Lyons AM;Li S;Wong AW;Gillis-Buck EM;Steinhart ZB;Lee Y;Apathy R;Lipke MJ;Smith JA;Zheng T;Boothby IC;Isaza E;Chan J;Acenas DD 2nd;Lee J;Macrae TA;Kyaw TS;Wu D;Ng DL;Gu W;York VA;Eskandarian HA;Callaway PC;Warrier L;Moreno ME;Levan J;Torres L;Farrington LA;Loudermilk RP;Koshal K;Zorn KC;Garcia-Beltran WF;Yang D;Astudillo MG;Bernstein BE;Gelfand JA;Ryan ET;Charles RC;Iafrate AJ;Lennerz JK;Miller S;Chiu CY;Stramer SL;Wilson MR;Manglik A;Ye CJ;Krogan NJ;Anderson MS;Cyster JG;Ernst JD;Wu AHB;Lynch KL;Bern C;Hsu PD;Marson A
Appropriate use and interpretation of serological tests for assessments of SARS-CoV-2 exposure, infection and potential immunity require accurate assay performance data. We conducted a head-to-head evaluation of 10 point-of-care (POC) style lateral flow assays (LFAs) and two laboratory-based enzyme-linked immunosorbent assays (ELISAs) to detect anti-SARS-CoV-2 IgM and IgG antibodies by 5-day time intervals from symptom onset and the specificity of each assay in pre-COVID-2019 specimens. The percent of seropositive individuals increased with time, peaking in the latest time interval tested (>20 days after symptom onset). Test specificity was heterogeneous (ranging from 84.3–100.0%) and was predominantly affected by variability in IgM results. LFA specificity could be increased by considering weak bands as negative, but this decreased detection of antibodies in a subset of SARS-CoV-2 real-time polymerase chain reaction (RT-PCR)-positive cases. Our results indicate the importance of seropositivity threshold determination and reader training for reliable LFA deployment. Informed use of serology will require evaluations covering the full spectrum of SARS-CoV-2 infections, from asymptomatic and mild infection to severe disease, and later convalescence. Well-designed studies to elucidate the mechanisms and serological correlates of protective immunity will be crucial to guide rational clinical and public health policies.
登录
查看更多内容
影响因子:
82.9
作者:
Long, Quan-Xin;Liu, Bai-Zhong;Huang, Ai-Long
通讯作者:
Huang, Ai-Long
影响因子:
82.9
作者:
Amanat F;Stadlbauer D;Strohmeier S;Nguyen THO;Chromikova V;McMahon M;Jiang K;Arunkumar GA;Jurczyszak D;Polanco J;Bermudez-Gonzalez M;Kleiner G;Aydillo T;Miorin L;Fierer DS;Lugo LA;Kojic EM;Stoever J;Liu STH;Cunningham-Rundles C;Felgner PL;Moran T;García-Sastre A;Caplivski D;Cheng AC;Kedzierska K;Vapalahti O;Hepojoki JM;Simon V;Krammer F
通讯作者:
Krammer F
影响因子:
82.9
作者:
He, Xi;Lau, Eric H. Y.;Leung, Gabriel M.
通讯作者:
Leung, Gabriel M.
影响因子:
19
作者:
Mizumoto, Kenji;Kagaya, Katsushi;Chowell, Gerardo
通讯作者:
Chowell, Gerardo
影响因子:
33.9
作者:
Kimball, Anne;Hatfield, Kelly M.;Jernigan, John A.
通讯作者:
Jernigan, John A.